BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2918755)

  • 1. Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations.
    Bird ML; Ueshima Y; Rowley JD; Haren JM; Vardiman JW
    Leukemia; 1989 Mar; 3(3):182-91. PubMed ID: 2918755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
    Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
    N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemia.
    Glassman AB; Harper-Allen EA; Hayes KJ; Hopwood VL; Gutterman EE; Zagryn SP
    Ann Clin Lab Sci; 1998; 28(1):24-9. PubMed ID: 9512781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implication of chromosomal aberrations in chronic B-lymphocytic leukaemia cells.
    Gahrton G; Juliusson G
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):389-92. PubMed ID: 3265508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal study for prognostic grouping in chronic lymphocytic leukemia.
    Junaid A; Rao PN; Adil MM
    J Coll Physicians Surg Pak; 2011 Jan; 21(1):19-22. PubMed ID: 21276379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
    Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
    Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
    Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
    Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
    Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia.
    Garcìa-Marco JA; Price CM; Ellis J; Morey M; Matutes E; Lens D; Colman S; Catovsky D
    Leukemia; 1996 Nov; 10(11):1705-11. PubMed ID: 8892671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cytogenetic results in B-cell chronic lymphocytic leukemia using immuno-purified leukemic cells.
    Brizard A; Brizard F; Lessard M; Dreyfus B; Guilhot F; Tanzer J
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):103-5. PubMed ID: 8511032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations.
    López C; Delgado J; Costa D; Conde L; Ghita G; Villamor N; Navarro A; Cazorla M; Gómez C; Arias A; Muñoz C; Baumann T; Rozman M; Aymerich M; Colomer D; Cobo F; Campo E; López-Guillermo A; Montserrat E; Carrió A
    Genes Chromosomes Cancer; 2012 Sep; 51(9):881-9. PubMed ID: 22619094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?
    El-Taweel M; Barin C; Cymbalista F; Eclache V
    Cancer Genet Cytogenet; 2009 Nov; 195(1):37-42. PubMed ID: 19837267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
    Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L;
    Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
    Schlette E; Bueso-Ramos C; Giles F; Glassman A; Hayes K; Medeiros LJ
    Am J Clin Pathol; 2001 Apr; 115(4):571-81. PubMed ID: 11293906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.